QUAGLIA, Marco
 Distribuzione geografica
Continente #
NA - Nord America 438
EU - Europa 227
AS - Asia 146
OC - Oceania 6
Totale 817
Nazione #
US - Stati Uniti d'America 435
IT - Italia 73
SG - Singapore 65
SE - Svezia 59
CN - Cina 38
IE - Irlanda 36
FR - Francia 15
GB - Regno Unito 12
DE - Germania 9
KR - Corea 8
AU - Australia 6
JP - Giappone 6
UA - Ucraina 6
BE - Belgio 5
FI - Finlandia 5
UZ - Uzbekistan 4
VN - Vietnam 4
CA - Canada 3
HK - Hong Kong 3
ID - Indonesia 3
IN - India 3
MY - Malesia 3
TH - Thailandia 3
AT - Austria 2
IL - Israele 2
LT - Lituania 2
PH - Filippine 2
PL - Polonia 2
HU - Ungheria 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 817
Città #
Santa Clara 88
Chandler 61
Singapore 56
Dublin 36
Ann Arbor 24
Ashburn 15
Beijing 15
Turin 15
Columbus 14
Medford 12
Nyköping 11
Torino 10
Fairfield 9
Princeton 9
Villeurbanne 9
Cambridge 7
Dearborn 7
Houston 7
Milan 6
Seattle 6
Brussels 5
Seoul 5
Woodbridge 5
Boston 4
Fremont 4
Guiyang 4
Jacksonville 4
Pisa 4
Wilmington 4
Falkenstein 3
Hangzhou 3
Helsinki 3
Hong Kong 3
Jakarta 3
Asti 2
Cagliari 2
Dong Ket 2
Guangzhou 2
Hebei 2
Leicester 2
London 2
Manchester 2
New York 2
Nuremberg 2
Rome 2
Tokyo 2
Warsaw 2
Washington 2
Atsugi 1
Bangkok 1
Baotou 1
Bologna 1
Bucheon 1
Busto Arsizio 1
Capo D'orlando 1
Chengdu 1
Florence 1
Frankfurt am Main 1
Frisco 1
Genova 1
Hadera 1
Haifa 1
Hilo 1
Innsbruck 1
Kuala Lumpur 1
Lappeenranta 1
Los Angeles 1
Melbourne 1
Mountain View 1
Mumbai 1
Nonthaburi 1
Norwalk 1
Osaka 1
Ottawa 1
Qingyuan 1
Ravenna 1
Redwood City 1
Reutlingen 1
Riverton 1
Riyadh 1
Rochester 1
San Diego 1
Setapak 1
Shanghai 1
Shenton Park 1
Soc Trang 1
Somerville 1
Tianjin 1
Vienna 1
Örebro 1
Totale 541
Nome #
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments 217
The MEST score provides earlier risk prediction in lgA nephropathy 100
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 69
Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection 67
Unexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy 63
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy 59
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy 49
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update 46
CAN TONSILLECTOMY MODIFY THE INNATE AND ADAPTIVE IMMUNITY PATHWAYS INVOLVED IN IGA NEPHROPATHY? 36
Dual Role of Extracellular Vesicles in Sepsis-Associated Kidney and Lung Injury 34
Circulating Extracellular Vesicles in Subarachnoid Hemorrhage Patients: Characterization and Cellular Effects 28
Stem Cell-Derived Extracellular Vesicles as Potential Therapeutic Approach for Acute Kidney Injury 26
Severe acute nephrotoxicity in a kidney transplant patient despite low tacrolimus levels: a possible interaction between donor and recipient genetic polymorphisms 16
The Role of TCF7L2 rs7903146 in Diabetes After Kidney Transplant: Results From a Single-Center Cohort and Meta-Analysis of the Literature 14
Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy 14
The effect of CYP3A5 6986A>G and ABCB1 3435C>T on tacrolimus dose-adjusted trough levels and acute rejection rates in renal transplant patients: a systematic review and meta-analysis 13
Pilot cohort study on the potential role of TCF7L2 rs7903146 on ischemic heart disease among non-diabetic kidney transplant recipients 9
Totale 860
Categoria #
all - tutte 3.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202032 0 0 0 0 0 0 9 5 6 6 2 4
2020/202187 3 7 2 7 10 5 5 9 14 3 13 9
2021/2022150 1 3 3 13 12 3 7 11 9 29 36 23
2022/2023188 17 20 8 9 19 41 18 8 25 2 12 9
2023/2024101 12 20 5 3 3 8 6 4 8 9 9 14
2024/2025210 5 21 24 22 98 40 0 0 0 0 0 0
Totale 860